207 related articles for article (PubMed ID: 29653879)
1. [Acquired hemophilia A associated with chronic myelomonocytic leukemia successfully treated by rituximab and azacitidine].
Dartevel A; Aubanel S; Pica GM; Faurie P; Fauché C; Boué Y; Peigne V
Rev Med Interne; 2018 Aug; 39(8):654-657. PubMed ID: 29653879
[TBL] [Abstract][Full Text] [Related]
2. A rare case of acquired haemophilia in a patient with chronic myelomonocytic leukaemia successfully treated with decitabine.
Shah D; Kumar R; Gaikazian S
Haemophilia; 2014 Jan; 20(1):e92-4. PubMed ID: 24261579
[No Abstract] [Full Text] [Related]
3. Chronic myelomonocytic leukaemia associated with acquired haemophilia A: case report and literature review.
Liang Y; Lu RN; Wang R; Zhang JF; Su W; Li JY; Zhang SJ; Lu H
Haemophilia; 2015 Jul; 21(4):e341-3. PubMed ID: 25982484
[No Abstract] [Full Text] [Related]
4. Generalized skin reactions in patients with MDS and CMML treated with azacitidine: Effective management with concomitant prednisolone.
Almeida AM; Pierdomenico F
Leuk Res; 2012 Sep; 36(9):e211-3. PubMed ID: 22622173
[No Abstract] [Full Text] [Related]
5. Acquired Hemophilia A Presenting as Intramuscular Hematoma.
Al-Shbool G; Vakiti A
J Investig Med High Impact Case Rep; 2018; 6():2324709618817572. PubMed ID: 30574513
[TBL] [Abstract][Full Text] [Related]
6. Myelofibrosis and acquired hemophilia A: a case report.
Wrobel M; Comio E; Gay V; Baroudi N; Meyer P; Chuniaud-Louche C; Hacini M; Pica GM
J Med Case Rep; 2016 May; 10(1):115. PubMed ID: 27154067
[TBL] [Abstract][Full Text] [Related]
7. [Isolated factor X deficiency in chronic myelomonocytic leukemia: Report of one case].
Zelada J; Cantó G; Berkovits A; Diocares G; López A
Rev Med Chil; 2015 Nov; 143(11):1490-3. PubMed ID: 26757875
[TBL] [Abstract][Full Text] [Related]
8. Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy.
Ichikawa S; Kohata K; Okitsu Y; Suzuki M; Nakajima S; Yamada MF; Onishi Y; Yamamoto J; Suzuki S; Ishizawa K; Kameoka J; Harigae H
Int J Hematol; 2009 Jul; 90(1):33-36. PubMed ID: 19484333
[TBL] [Abstract][Full Text] [Related]
9. Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.
Scott BL; Ramakrishnan A; Storer B; Becker PS; Petersdorf S; Estey EH; Deeg HJ
Br J Haematol; 2010 Mar; 148(6):944-7. PubMed ID: 20064151
[TBL] [Abstract][Full Text] [Related]
10. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
11. Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Hilmi M; Bally C; Burns R; Lorillon G; Bergeron A; Fenaux P; Ades L
Ann Hematol; 2018 Mar; 97(3):541-542. PubMed ID: 29170809
[No Abstract] [Full Text] [Related]
12. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.
Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P
Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255
[No Abstract] [Full Text] [Related]
13. Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.
Niscola P; Siniscalchi A; Tendas A; Scaramucci L; Fratoni S; de Fabritiis P; Caravita T
Ann Hematol; 2015 Oct; 94(10):1753-4. PubMed ID: 26088814
[No Abstract] [Full Text] [Related]
14. [Efficiency of rituximab in acquired hemophilia: report of two cases and review of literature].
Millet A; Decaux O; Bareau B; Guillet B; Cazalets C; Perlat A; Jego P; Grosbois B
Rev Med Interne; 2007 Dec; 28(12):862-5. PubMed ID: 17707554
[TBL] [Abstract][Full Text] [Related]
15. [Acquired hemophilia A treated with rituximab. Report of one case].
Conte L G; Figueroa M G; Aravena R P; Gonzáles G N; Araos H D; Cuneo V M
Rev Med Chil; 2011 Mar; 139(3):357-61. PubMed ID: 21879169
[TBL] [Abstract][Full Text] [Related]
16. Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.
Voso MT; Breccia M; Lunghi M; Poloni A; Niscola P; Finelli C; Bari A; Musto P; Zambello R; Fianchi L; Alimena G; Leone G
Eur J Haematol; 2013 Apr; 90(4):345-8. PubMed ID: 23336938
[TBL] [Abstract][Full Text] [Related]
17. Acquired Hemophilia A: A Case Report.
Shen M; Wang S; Sessa J; Hanna A; Axelrad A; Ali F
J Pharm Pract; 2020 Aug; 33(4):562-566. PubMed ID: 30727803
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review.
Thorpe M; Montalvão A; Pierdomenico F; Moita F; Almeida A
Leuk Res; 2012 Aug; 36(8):1071-3. PubMed ID: 22607959
[TBL] [Abstract][Full Text] [Related]
19. Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization.
Serrao A; Loglisci G; Salaroli A; Zacheo I; Alimena G; Breccia M
Leuk Lymphoma; 2013 Feb; 54(2):411-2. PubMed ID: 22694794
[No Abstract] [Full Text] [Related]
20. [Effectiveness of azacitidine in chronic myelomonocytic leukemia harboring del(20q) - a case report].
Manabe M; Okita J; Takakuwa T; Harada N; Aoyama Y; Kumura T; Ohta T; Furukawa Y; Mugitani A
Gan To Kagaku Ryoho; 2014 Jun; 41(6):781-4. PubMed ID: 25129095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
